New Delhi: CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, has signed a MoU with its industrial partner, Phyto Biotech, Kolkata, to formalize Transfer of Technology for production of unique autoclavable Super Oxide Dismutase (SOD) enzyme, used in cosmetic, food and pharmaceutical industries for end applications, like developing anti-ageing creams, extending shelf life of fruits and vegetables and during cryo-surgery and preservation of organelles, respectively. The licensing has brought together the CSIR and the industry to enable commercial production of desired standard SOD so as to create a global niche for the country.
The enzyme was discovered by CSIR-IHBT during a survey at an altitude of over 10, 000 ftin the Western Himalayan region from Potentilaastrosanguniaplant growing under snow cover. Persistent hard work over the years has resulted in the isolation of the SOD gene. Thereafter,a protocol was developed for cloning of the gene in E.coli. The enzyme thus produced,retained the same unique feature as that of the native plant. Applying the knowledge of bioinformatics, the enzyme has been further engineeredby mutation of a single amino acid to increase its consistency and thermo-stability.
The characteristic features of this SOD lies in its stability and functionality ranging from sub-zero to high temperature of>40oc with varying specific activity. Owing to its high antioxidant properties and multiple uses, SOD enjoys high demand and price in the global market.
"Believer - Humanitarian - Habit of Success" Sukumar Balakrishnan is the Founder of JB GROUP, a 500 Crore National Organization with over 150 Direct & 1200 indirect professionals operating from 5 major cities in India. Jayalakshmi Balakrishnan Group, a multi-faceted group venturing into, E- Commerce and Import-Export (INNOKAIZ), Retail and Wholesale (JB MART), Food and Beverages (KRISHNA FOODS ), Real Estate (Constructions on sites, Interior scaping, Facility Management)
Total Pageviews
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment